Pseudocholinesterase Deficiency Considerations: A Case Study

Bryant W Cornelius, Todd M Jacobs, Bryant W Cornelius, Todd M Jacobs

Abstract

Pseudocholinesterase deficiency, sometimes called butyrylcholinesterase deficiency, is a rare disorder in which the neuromuscular blocking drugs succinylcholine and mivacurium cannot be metabolized properly in the blood plasma. This disorder can either be acquired as a result of certain comorbidities or it can be inherited genetically. Anesthesia providers must understand the pathophysiology of pseudocholinesterase deficiency and be prepared to safely and effectively manage patients who show signs and symptoms consistent with the disorder after the use of the indicated neuromuscular blocking drugs. This article summarizes the pharmacologic and physiologic data relevant to understanding the basic pathophysiology associated with pseudocholinesterase deficiency and illustrates a case study of a young woman suspected of having the disorder after a prolonged delay in emergence from general anesthesia.

Keywords: Butyrylcholinesterase deficiency; Delayed emergence; General anesthesia; Pseudocholinesterase deficiency; Residual neuromuscular blockade.

© 2020 by the American Dental Society of Anesthesiology.

Figures

Figure 1
Figure 1
Comparison of depolarizing and nondepolarizing blocks.
Figure 2
Figure 2
(A) Neuromuscular junction. (B) Muscle-type nicotinic acetylcholine receptor (N1AChR).
Figure 3.
Figure 3.
Molecular structures of acetylcholine and succinylcholine.

References

    1. Hill SA. Pharmacokinetics of drug infusions. Contin Educ Anaesth Crit Care Pain. 2004;4:76–80.
    1. Cornelius BW. Total intravenous anesthesia for longer office-based procedures. Presented at American Society of Dentist Anesthesiologists 2019 Annual Scientific Session; Orlando Fla; April 25 2019.
    1. Howard SK, Chu LK, Goldhaberr-Fiebert SN, Gaba DM, Harrison TK. Stanford Anesthesia Cognitive Aid Group. Emergency Manual: Cognitive Aids for Perioperative Events; Delayed emergence algorithm. 2013. Available at: Creative Commons BY-NC-ND. 2013.
    1. Renew JR. Clinical use of neuromuscular blocking drugs in anesthesia. UpToDate February 2020. Available at: Accessed April 2020.
    1. Omar A, Marwaha K, Bollu PC. Physiology, neuromuscular junction. NCBI Bookshelf. StatPearls Publishing; 2020. Available at: Accessed April 2020.
    1. Waller DG, Sampson AP. Medical Pharmacology and Therapeutics 5th ed. Edinburgh, UK: Elsevier;; 2018.
    1. Miller RD. Neuromuscular Blocking Drugs. In: Miller RD, editor. Basics of Anesthesia 7th ed. Philadelphia, Pa: Elsevier;; 2018. pp. 156–175.
    1. Chan JM. Drug Metabolism and Pharmacogenetics. In: Hemmings HC, Egan D, editors. Pharmacology and Physiology for Anesthesia 2nd ed. Philadelphia, Pa: Elsevier;; 2019. pp. 70–90.
    1. Appiah-Ankam J, Hunter JM. Pharmacology of neuromuscular blocking drugs. Contin Educ Anaesth Crit Care Pain. 2004;4:2–7.
    1. Davis J, Britten JJ, Morgan M. Cholinesterase: its significance in anaesthetic practice. Anaesthesia. 1997;52:244–260.
    1. Wong SF, Chung F. Succinylcholine-associated postoperative myalgia. Anaesthesia. 2000;55:144–152.
    1. Orebaugh SL. Succinylcholine: adverse effects and alternatives in emergency medicine. Am J Emerg Med. 1999;17:715–721.
    1. Andersson ML, Moller AM, Wildgaard K. Butyrylcholinesterase deficiency and its clinical importance in anesthesia: a systemic review. Anaesthesia. 2019;74:518–528.
    1. Robles A, Michael M, McCallum R. Pseudocholinesterase deficiency: what the proceduralists needs to know. Am J Med Sci. 2019;357:263–267.
    1. Trujillo R, West WP. Pseudocholinesterase deficiency. NCBI Bookshelf StatPearls Publishing; January 2020. Available at: Accessed April 2020.
    1. Wichmann S, Faerk G, Bundgaard JR, Gatke MR. Patients with prolonged effect of succinylcholine or mivacurium had novel mutations in the butyrylcholinesterase gene. Pharmacogenet Genom. 2016;26:351–356.
    1. Zang C, Cau H. Gang Wan Z, Wang J. Prolonged neuromuscular block associated with cholinesterase deficiency. Medicine. 2018;97:52.
    1. Chang B, Raker R, Garcia PS. Bispectral index monitoring and intraoperative awareness. World Federation of Societies of Anethesiologists December 2019. Available at: Accessed July 2020.
    1. Kompoliti K, Horn SS. Textbook of Clinical Neurology 3rd ed. Philadelphia, Pa: Elsevier;; 2007.
    1. Goetz S, Pritts B, Cornelius B. Sugammadex: efficacy and practicality in the dental office. Anesth Prog. 2018;65:113–118.
    1. Cooper RM. Extubation following aesthesia. UpToDate October 2019. Available from: Accessed April 2020.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다